Year 2016

WSIS2016: Software Licensing Matters – To Everybody

A special committee at the World Intellectual Property Organisation on software licensing, a globally harmonized software licence model and a dispute resolution system were among the ideas presented to the World Intellectual Property Organization (WIPO) at panel it hosted at day one of the 2016 WSIS Forum meeting in Geneva.

MSF Issues In-Depth Report On R&D And Drug Prices

Médecins Sans Frontières (MSF, Doctor Without Borders) today announced a report detailing what it calls failings in the current system for developing new drugs in ways that all patients can afford and access, and providing proposed policy options for addressing the problems.

Special Report: The Battle For Biosimilars In India

[story updated] Biosimilar drugs hold out big opportunities for India’s drug companies. But the future is fraught with challenges. One key challenge is regulations.

What does this mean for countries like India, an emerging market for biosimilars? How will the evolving global regulatory environment on biosimilars impact patients?

Last month, both these questions came to the fore as the battle over biosimilars moved centre stage in this country in the wake of an interim order by the Delhi High Court, and then another decision by a Division Bench of the same court which took a different view.

Discussions Continue On How To Govern WHO Interactions With Outside Actors

The World Health Organization interacts with a large number of actors aside from governments, such as industry, philanthropic organisations, academia, and civil society. With an eye to preventing undue influence on the work of the organisation, member states have been trying to finalise a draft framework on WHO interaction with those actors. This week, what was seen as a last effort at reaching a consensual text did not quite meet the goal and some additional informal discussions are expected to take place before the annual World Health Assembly in late May.

Measure Allowing Federal Courts To Handle Trade Secrets Claims Clears US Congress

Legislation authorising federal courts to hear cases involving theft of trade secrets passed the US House of Representatives on 27 April and is now headed for an expected signature by President Barack Obama. Final enactment of the “Defend Trade Secrets Act of 2016” (DTSA), along with the 14 April adoption by the European Parliament of the EU Trade Secrets Directive, boosts protections on both sides of the Atlantic but not uniformly, intellectual property lawyers said.

Surprise! Much Work Being Done On Transparency Of Patents On Medicines

James Love writes: In a recent paper by Reed F. Beall and Amir Attaran [KEI's April 12, 2016 comment here: http://www.keionline.org/node/2467], and in the WIPO seminar discussions about the paper, the authors have held themselves out as more or less lonely voices calling for transparency of patent landscapes on essential medicines. This surprised and offended the many people who have not only been concerned about the lack of transparency on patent landscapes, but have been doing most of the work in digging out the facts, and/or proposing remedies.

Why We Celebrated World Intellectual Property Day 2016

Corey Salsberg writes: Yesterday was World Intellectual Property Day. April 26 is the day we celebrate and call attention to the global intellectual property (IP) system. Why do we set aside a day for the entire world to stop and reflect on a subject that, for many, may seem more at home in board rooms, lecture halls, and legislatures, than in cafes, farms, and internet blogs?

On IP Protection, USTR Finds Fault With China, India … And Switzerland?

The Office of the United States Trade Representative (USTR) does not hesitate to add even its closest friends to its annual list of concerns about possible inadequate protection of US intellectual property rights. So this year, along with perennial listees China, India and dozens of others, vigorous IP-rights defender Switzerland makes an appearance. The annual Special 301 report was issued today, and in its press release this year, USTR also included its primary client in publishing the list - the rightsholder industry.

New Guide To WIPO Governance

A new publication offering an overview of the World Intellectual Property Organization governance system seeks to contribute to ongoing debates on the organisation's governance, according to its author.

Drawn Out Battle Over Genetic Resources Dampens Africa’s Hopes

Chidi Oguamanam writes: The global South is full of significant, diverse biological and genetic resources. It’s also home to most of the world’s indigenous communities. This is why developing countries are sensitive about protecting their genetic resources and traditional knowledge.

Indigenous communities enjoy a close relationship with nature. Genetic resources are central to producing their traditional knowledge. This drives innovations in agriculture, medicines and conservation. But global intellectual property frameworks – the legal mechanisms for securing knowledge ownership – still haven’t taken this reality into account.